Yulia Liubomirski

932 total citations
11 papers, 689 citations indexed

About

Yulia Liubomirski is a scholar working on Oncology, Molecular Biology and Immunology. According to data from OpenAlex, Yulia Liubomirski has authored 11 papers receiving a total of 689 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Oncology, 4 papers in Molecular Biology and 4 papers in Immunology. Recurrent topics in Yulia Liubomirski's work include Cancer Cells and Metastasis (5 papers), Chemokine receptors and signaling (4 papers) and Mesenchymal stem cell research (3 papers). Yulia Liubomirski is often cited by papers focused on Cancer Cells and Metastasis (5 papers), Chemokine receptors and signaling (4 papers) and Mesenchymal stem cell research (3 papers). Yulia Liubomirski collaborates with scholars based in Israel, Germany and Portugal. Yulia Liubomirski's co-authors include Adit Ben‐Baruch, Tsipi Meshel, Shalom Lerrer, Rita C. Acúrcio, Galia Tiram, Bárbara Carreira, Ronit Satchi‐Fainaro, Helena F. Florindo, Daniella Vaskovich‐Koubi and Ron Kleiner and has published in prestigious journals such as Nature Nanotechnology, Cancer Research and Frontiers in Immunology.

In The Last Decade

Yulia Liubomirski

11 papers receiving 682 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yulia Liubomirski Israel 9 268 228 217 175 106 11 689
Vida Hashemi Iran 13 260 1.0× 254 1.1× 363 1.7× 113 0.6× 115 1.1× 20 839
Nima Taefehshokr Iran 13 156 0.6× 246 1.1× 185 0.9× 115 0.7× 137 1.3× 21 613
S Mestiri Qatar 9 406 1.5× 230 1.0× 278 1.3× 197 1.1× 107 1.0× 21 924
Leila Mohamed Khosroshahi Iran 10 201 0.8× 199 0.9× 128 0.6× 101 0.6× 43 0.4× 19 516
Manasi P. Jogalekar United States 13 173 0.6× 206 0.9× 130 0.6× 72 0.4× 72 0.7× 21 593
Sofia Mubarika Haryana Indonesia 20 371 1.4× 392 1.7× 118 0.5× 114 0.7× 233 2.2× 104 1.1k
Jian Ding China 13 187 0.7× 322 1.4× 119 0.5× 70 0.4× 145 1.4× 32 819
Lisa M. Chelstrom United States 16 181 0.7× 272 1.2× 213 1.0× 47 0.3× 56 0.5× 33 907

Countries citing papers authored by Yulia Liubomirski

Since Specialization
Citations

This map shows the geographic impact of Yulia Liubomirski's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yulia Liubomirski with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yulia Liubomirski more than expected).

Fields of papers citing papers by Yulia Liubomirski

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yulia Liubomirski. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yulia Liubomirski. The network helps show where Yulia Liubomirski may publish in the future.

Co-authorship network of co-authors of Yulia Liubomirski

This figure shows the co-authorship network connecting the top 25 collaborators of Yulia Liubomirski. A scholar is included among the top collaborators of Yulia Liubomirski based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yulia Liubomirski. Yulia Liubomirski is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Vaskovich‐Koubi, Daniella, Ron Kleiner, Yulia Liubomirski, et al.. (2021). Abstract 714: From cancer to COVID-19- development of a dendritic cell-targeted nano-vaccine for prevention and therapy of COVID-19. Cancer Research. 81(13_Supplement). 714–714. 1 indexed citations
2.
Morein, Dina, Yulia Liubomirski, Tsipi Meshel, et al.. (2021). Persistent Inflammatory Stimulation Drives the Conversion of MSCs to Inflammatory CAFs That Promote Pro-Metastatic Characteristics in Breast Cancer Cells. Cancers. 13(6). 1472–1472. 36 indexed citations
3.
Florindo, Helena F., Ron Kleiner, Daniella Vaskovich‐Koubi, et al.. (2020). Immune-mediated approaches against COVID-19. Nature Nanotechnology. 15(8). 630–645. 249 indexed citations
4.
Liubomirski, Yulia & Adit Ben‐Baruch. (2020). Notch-Inflammation Networks in Regulation of Breast Cancer Progression. Cells. 9(7). 1576–1576. 20 indexed citations
5.
Liubomirski, Yulia, Shalom Lerrer, Tsipi Meshel, et al.. (2019). Tumor-Stroma-Inflammation Networks Promote Pro-metastatic Chemokines and Aggressiveness Characteristics in Triple-Negative Breast Cancer. Frontiers in Immunology. 10. 757–757. 138 indexed citations
6.
Liubomirski, Yulia, Shalom Lerrer, Tsipi Meshel, et al.. (2019). Notch-Mediated Tumor-Stroma-Inflammation Networks Promote Invasive Properties and CXCL8 Expression in Triple-Negative Breast Cancer. Frontiers in Immunology. 10. 804–804. 49 indexed citations
7.
Ben‐Baruch, Adit, et al.. (2019). E-103 Inflammation-driven networks in the regulation of breast cancer progression. JAIDS Journal of Acquired Immune Deficiency Syndromes. 81(1). 41–41. 1 indexed citations
8.
Lerrer, Shalom, Yulia Liubomirski, Alexander Bott, et al.. (2017). Co-Inflammatory Roles of TGFβ1 in the Presence of TNFα Drive a Pro-inflammatory Fate in Mesenchymal Stem Cells. Frontiers in Immunology. 8. 479–479. 28 indexed citations
9.
Lerrer, Shalom, Yulia Liubomirski, Leonor Leider–Trejo, et al.. (2015). Regulation of the inflammatory profile of stromal cells in human breast cancer: prominent roles for TNF-α and the NF-κB pathway. Stem Cell Research & Therapy. 6(1). 87–87. 109 indexed citations
10.
Liubomirski, Yulia, Tsipi Meshel, Anastasia Abashidze, et al.. (2014). The inflammatory cytokine TNFα cooperates with Ras in elevating metastasis and turns WT-Ras to a tumor-promoting entity in MCF-7 cells. BMC Cancer. 14(1). 158–158. 17 indexed citations
11.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Vida Hashemi Breakdown of academic impact, for papers by Nima Taefehshokr Breakdown of academic impact, for papers by S Mestiri Breakdown of academic impact, for papers by Leila Mohamed Khosroshahi Breakdown of academic impact, for papers by Manasi P. Jogalekar Breakdown of academic impact, for papers by Sofia Mubarika Haryana Breakdown of academic impact, for papers by Jian Ding Breakdown of academic impact, for papers by Lisa M. Chelstrom
Rankless by CCL
2026